Oaktree Acquisition Corp. III Life Sciences (OACC) Interest & Investment Income (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Interest & Investment Income of $1.9 million for Q1 2026, down 12.02% on a YoY basis from $2.1 million in Q1 2025, and down 9.48% quarter-over-quarter from $2.0 million in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Interest & Investment Income (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Interest & Investment Income for 2 years, with the latest figure at $1.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income fell 12.02% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (changed N/A YoY), and the FY2025 full-year result was $8.5 million, up 434.04% from the prior year.
  • Interest & Investment Income for Q1 2026 stood at $1.9 million, down from $2.0 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $2.2 million in Q3 2025, with the low at $1.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 4.30 Mn
2 Centurion Acquisition 312.80 Mn 312.80 Mn - 2.72 Mn
3 Berto Acquisition 312.16 Mn 312.16 Mn - 2.70 Mn
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 2.98 Mn
5 Churchill Capital Corp IX 310.50 Mn 310.50 Mn - 2.65 Mn
6 WEN Acquisition 308.55 Mn 308.55 Mn - 2.97 Mn
7 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn - -
8 Bold Eagle Acquisition 274.25 Mn 274.25 Mn - 2.37 Mn
9 Soulpower Acquisition 265.04 Mn 265.04 Mn - 2.27 Mn
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - 1.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.85 Mn
Dec 31, 2025 2.04 Mn
Sep 30, 2025 2.19 Mn
Jun 30, 2025 2.14 Mn
Mar 31, 2025 2.10 Mn